back to company universe
Healthcare

Loop Genomics

Loop Genomics provides long-read sequencing solutions across a diverse set of research and clinical applications. Our platform for long-read DNA sequencing transforms short-read DNA sequencers into long-read sequencing machines.

sources
1
Evidence entries preserved.
affiliations
1
Y Combinator
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Y Combinator

yc-company-directory #3694

Loop Genomics provides long-read sequencing solutions across a diverse set of research and clinical applications. Our platform for long-read DNA sequencing transforms short-read DNA sequencers into long-read sequencing machines.

source
generated read
High Signal interpretation

Loop Genomics is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
long-read DNA sequencingresearch and clinical applicationslong-read sequencing solutionsshort-read DNA sequencerslong-read sequencing machinesLoop Genomics
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to Loop Genomics

Healthcare · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

20n

match 71

The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that predict DNA design for novel industrial biotech and health applications. At 20n, we are taking a fresh look at turning biological data into information. We approach it as a big data

shared extracted concept terms: sequenc, read, dna; shared product terms: read, dna, sequenc, application; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator

Shield Bio

match 45

Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.

shared extracted concept terms: sequenc, clinical; shared product terms: sequenc, clinical; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator

Gleam

match 45

Gleam automates data entry for clinical research sites.

shared extracted concept terms: clinical, research; shared product terms: clinical, research; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator

CliniSpan Health

match 44

CliniSpan Health has built an Influencer Relationship Management Platform (IRM) for clinical research.

shared extracted concept terms: clinical, research; shared product terms: clinical, research; shared product theme: health and clinical care; same category: Healthcare

One Codex

match 40

One Codex is a data platform for applied microbial genomics, enabling new and valuable applications in clinical diagnostics, food safety, and biosecurity. Acquired by Invitae (NVTA) in February 2021. Spun out as an independent company in September 2022.

shared extracted concept terms: clinical; shared product terms: genomic, clinical, application; shared product theme: health and clinical care; shared affiliation: Y Combinator

RealSynth

match 36

Fully custom synthetic annotated image data for machine learning applications

shared extracted concept terms: application, machine; shared product terms: application, machine